IONOE: Improving Outcomes of Necrotising Otitis Externa
Study Details
Study Description
Brief Summary
A UK multi-centre prospective observational study of clinically possible cases of NOE.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
Patients with clinically possible NOE for whom CT imaging is requested will be recruited to the study by hospital staff at 5-15 UK sites.
NOE remains a relatively uncommon condition with UK - ENT surgeons report seeing between 1 and 10 cases per year. Extrapolating from pilot data, it is anticipated that 820 eligible patients will be identified in 10 hospital sites over a 12-month recruitment period of which approximately 90 would be definite cases of NOE.
Patients will be consented prior to or after CT imaging for a diagnosis of clinically possible NOE. After providing consent, patients will be asked to complete an EQ-5D-3L questionnaire. For patients consented remotely, this questionnaire will be completed via an interview. Local study staff will complete an online case report form hosted on Redcap™ for each patient including data on demographics, co-morbidities, clinical presentation, investigations and surgical and antibiotic management. Local study staff will review patients' hospital notes and contact patients' GPs by telephone 1-year post recruitment to assess clinical outcomes and mortality rates. Patients will then be contacted 12 months (+/- 1 month) post-recruitment by telephone by local study staff in order to confirm clinical outcomes (e.g. relapse) and gain information to complete the EQ-5D-3L questionnaire a second time.
All CT scans performed at recruitment and any other CT and/or MRI scans performed in the 12-month follow-up period will be de-identified and uploaded by local sites to an online, web-based secure repository for radiological images. Subspecialised radiologists blinded to clinical details will assess the images according to pre-agreed, standardised criteria.
Selected sites will be asked to freeze any P. aeruginosa isolates routinely collected via ear swabs as part of clinical care from enrolled participants within 14 days of CT imaging. These de-identified samples may be sent from sites to undergo genotypic and phenotypic analysis at the University of Oxford for virulence factors to assess the relationship between these and disease severity. Of note, no samples beyond those routinely collected as part of the patients' care will be collected and no patient tissue samples will be stored. These samples will not contain any biological or genetic material from the patient.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Participants Adults undergoing a CT scan to investigate possible NOE. |
Other: Observational Study
Observational study
|
Outcome Measures
Primary Outcome Measures
- Demographic, management and outcome data [12 months]
Describe the prevalence, demographics, clinical presentation, surgical and medical management and outcomes of clinically possible cases of NOE in the UK.
Secondary Outcome Measures
- Risk Factors for NOE [12 months]
Identify risk factors for clinically possible NOE, SOE and definite NOE in the UK
- Antibiotic Management of NOE [12 months]
Understand whether differences in antibiotic choice and duration impact on clinical outcome of patients with SOE or NOE in the UK.
- Role of Surgical Management in NOE [12 months]
Describe the role of superficial sampling of the EAC, deep surgical sampling and debridement in cases of clinically possible NOE in the UK.
- Economic Costs of NOE [12 months]
Investigate the economic impact of clinically possible NOE in UK as measured by hospital bed days.
- Affect of NOE on Generic Health Status [12 months]
Assess changes in generic health status as measured using EQ-5D-3L in the year following enrolment of clinically possible NOE cases.
- Radiological Changes of NOE [12 months]
Assess agreement in interpretation of CT and/or MRI scans of clinically possible cases of NOE between locally reporting radiologists and blinded neuroradiology specialists working according to proposed standardised radiological criteria.
- Pseudomonas Aeruginosa [12 months]
Genotypic and phenotypic analysis of P. aeruginosa isolates to assess relationship between virulence markers and disease severity.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Adult patients (≥ 18 years old).
-
Clinical diagnosis of possible NOE for whom CT imaging is requested or has been done as part of routine clinical care.
Exclusion Criteria:
-
Any previous clinical diagnosis of NOE.
-
CT performed or due to be performed at hospital other than recruiting study site.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Oxford University Hospitals NHS Foundation Trust | Oxford | Oxfordshire | United Kingdom | OX3 9DU |
Sponsors and Collaborators
- University of Oxford
Investigators
- Principal Investigator: Susanne Hodgson, PhD, University of Oxford
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- IRAS:280342